Abstract
The production of an antibody which reacts with endocardium, blood vessels, and cardiac interstitial tissue (EVI factor) was experimentally obtained in rabbits immunized either with heterologous heart crude antigen, Trypanosoma cruzi antigen, a mixture of heart and T. cruzi antigens, kidney antigen or lung antigen, and complete Freund's adjuvant. Immunization lasted 2 months, with multiple subcutaneous and foot pad injections being made every 15th day. Preimmunization serum from each animal was used as normal control serum. Rabbit sera were tested by indirect immunofluorescence against mouse heart and skeletal muscle unfixed cryostat sections and revealed by fluoresceinated anti-rabbit globulin diluted 1:80. The highest titers appeared with anti-heart sera (1:192) and with anti-heart/T. cruzi sera (1:96). Incorporation of T. cruzi antigen in heart extract did not increase EVI antibody titers. It is suggested that the EVI factor is an antibody to many antigenic determinants, the majority of which are present in the heart and some of which cross-react with T. cruzi.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The American journal of tropical medicine and hygiene
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
